Filing Details
- Accession Number:
- 0001209191-13-029935
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-05-31 20:02:56
- Reporting Period:
- 2013-05-31
- Filing Date:
- 2013-05-31
- Accepted Time:
- 2013-05-31 20:02:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 949699 | Pharmacyclics Inc | PCYC | Pharmaceutical Preparations (2834) | 943148201 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1559226 | Jesse Mcgreivy | C/O Pharmacyclics, Inc. 995 East Arques Avenue Sunnyvale CA 94085 | Vp, Clinical Science | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-05-31 | 9,479 | $25.33 | 9,479 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-05-31 | 5,000 | $61.60 | 14,479 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-05-31 | 14,479 | $91.13 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-05-31 | 9,479 | $0.00 | 9,479 | $25.33 |
| Common Stock | Stock Option (Right t Buy) | Disposition | 2013-05-31 | 5,000 | $0.00 | 5,000 | $61.60 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 25,521 | 2012-04-16 | 2022-04-16 | No | 4 | M | Direct |
| 35,000 | 2013-04-11 | 2022-10-26 | No | 4 | M | Direct |
Footnotes
- The shares subject to the option will vest as follows: 25% of the shares subject to the option will vest on April 16, 2013 and 1/36th of the remaining shares will vest monthly thereafter.
- The option vests 6/48 on April 11, 2013; the remainder vests proportionately on each of April 11, 2014, April 11, 2015 and April 11, 2016. The vesting of the options are subject to satisfaction of certain performance criteria.
Billionaire Hedge Funds
